TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 20:29 | 3/26/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | D | P | 204 | 5.10 | 0 | 40 | 2 | 2,017 | I | |||||||||||||||
3/25/24 21:44 | 3/21/24 | TSVT | 2Seventy Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | D | P.dm | 3,899 | 5.02 | 0 | 777 | 65 | 1,977 | I | |||||||||||||||
3/6/24 19:32 | 3/4/24 | WGS | Genedx Holdings Corp. | DE | Health | Health | Health Services | Casdin Capital, LLC | NY | DT | P.m | 358 | 8.74 | 0 | 41 | 1 | 3,473 | D | |||||||||||||||
6/18/20 17:29 | 6/16/20 | GBIO | Generation Bio Co. | DE | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | T | P.d | 12,350 | 19.00 | 0 | 650 | 68 | 1,611 | I | |||||||||||||||
7/22/19 16:31 | 7/22/19 | FULC | Fulcrum Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | T | P.d | 2,217 | 15.84 | 0 | 140 | 30 | 604 | I | |||||||||||||||
7/23/18 20:12 | 7/23/18 | CNST | Constellation Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Casdin Capital, LLC | NY | T | P.d | 4,000 | 15.00 | 0 | 267 | 159 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |